- Atrium Health affected by Oracle Health breach
- Allstate accuses Chicago ASC of running fraud scheme
- 5 DSOs making headlines
- Fix it before it’s lost: How ambient clinical intelligence closes the RCM gap
- Inside the shift to concierge medicine: 4 lessons from health system leaders
- Revisiting Pharma’s tariff reality
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- AHA: Cyber resilience critical to prevent nation-state hacks
- Elevance senior executive fights DOJ deposition bid in Medicare Advantage fraud case
- A split is emerging in healthcare’s workforce pipeline
- The hospitals, health systems cutting jobs in 2026
- 19 women making moves in healthcare
- Judy Faulkner’s long game: An Epic that no one can buy
- Why WakeMed’s CEO says his system will ‘survive’ but not ‘thrive’ alone
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- New York system opens outpatient pavilion
- What cardiology ASCs still haven’t mastered
- Texas dental practice relocates into 6K-square-foot facility
- Surgery Partners opens 9 ASCs in 12 months amid ‘fickle’ M&A market
- Medit launches global orthodontics division, acquires California training institute
- What’s going on behind ASC de novo development?
- Pennsylvania enacts dental faculty bill
- Payer denials remain elevated, but aren’t accelerating: Tenet
- Dental industry eyes increased payer oversight, transparency: 4 updates
- Dr. Michael Durbin named president of the American Association of Orthodontists
- Arkansas dental school launches partnership with children’s hospital
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Woodside Health acquires 40K-square-foot MOB
- Remarks at the 13th Annual Conference on Financial Market Regulation
- Eko Health appoints cardiologist as chief medical officer
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- North Carolina physician practice acquired
- Straine Dental unifies 3 operating companies under single brand
- Thomas Jefferson University to launch new nurse anesthesia program
- Is dentistry losing its spark?
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’ for hospital medicine
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Wisconsin releases statewide mental health action plan: 4 things to know
- Alabama behavioral health provider opens outpatient clinic
- Oscar Health's profit hits $679M, membership rises in Q1
- Kaiser Permanente eases ‘last mile to licensure’ for mental health workers
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- Cannabis most commonly microdosed substance in US: Study
- FDA Authorizes Fruit-Flavored Vapes for Adults
- White House outlines drug control strategy: What healthcare leaders should know
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Inside the gaps in fertility and surrogacy systems
- Lilly to invest $4.5B more into massive Indiana manufacturing complex
- CVS execs say company on track to meet MA margin goals by 2028
- Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- California hospitals sue Anthem over out-of-network care policy
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- UnitedHealthcare to reduce prior auth requirements by 30%
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Novartis to close German manufacturing site, cutting 220 jobs
- BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- Sanofi expands AI capabilities, investing $294M to scale Toronto hub
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
In this MedPage Opinion piece, the American Medical Association and American Academy of Pediatrics weight in on Murthy v. Missouri, the First Amendment case now before the US Supreme Court.
They present a truly stunning array of factual errors, biased opinions, and unsubstantiated claims.
One is tempted to take them up on the science, or the politics, or the philosophy of "First do no harm," but underlying it all - we should always remember why the First Amendment is indeed First.
https://www.medpagetoday.com/opinion/second-opinions/109343
Medical Misinfo Runs Rampant Online. The Gov't Must Retain the Right to Intervene.
— Combating vaccine falsehoods and other inaccurate claims protects public health
Online misinformation about vaccines harm patients, undermines trust in science, and places additional burdens on our healthcare system through reduced vaccine uptake. All in all, it is a barrier to protecting public health.
As physicians, we see the damages caused by vaccine misinformation firsthand, and we welcome conversations with our patients about vaccine safety and efficacy. However, the widespread proliferation of misinformation and disinformation has triggered higher levels of vaccine hesitancy and refusal, allowing a resurgence of vaccine-preventable diseases such as measles that we had nearly eradicated.
Preventing the spread of vaccine misinformation without infringing on free speech protections in the First Amendment is a thorny legal issue that is at the heart of a landmark case now before the U.S. Supreme Court, Murthy et al. v. Missouri et al. The nation's leading healthcare organizations, including ours (the American Academy of Pediatrics and the American Medical Association) and others -- and the hundreds of thousands of physicians across the country who we represent -- believe that vaccine misinformation poses a grave threat to public health. As outlined in an amicus brief we filed in this case, we seek to partner with the federal government to advance factual information.
In Murthy v. Missouri, plaintiffs including the attorneys general of Missouri and Louisiana argue that several federal agencies and the Biden administration engaged in censorship during the pandemic by urging private social media companies to stop the spread of discredited medical falsehoods from their platforms to save lives. Oral arguments took place last week, and a ruling is expected this summer.
At stake in this case is what tools the government and public health agencies have at their disposal to combat medical misinformation. Without getting into the legal arguments on both sides, one thing is clear: to strip away government power to raise the alarm about patently false information on life-saving vaccines -- when illness and lives hang in the balance -- would be a devastating outcome.
Vaccines have long been one of the safest and most powerful tools in protecting public health. Vaccines save lives by not only protecting vaccinated individuals against infection and reducing the burden of unnecessary hospitalization on our healthcare system, but also by helping prevent the spread of disease.
Medical misinformation that promotes non-scientifically validated remedies can and often does result in harm. Both the FDA and CDC warned of serious adverse effects from people taking ivermectin, an anti-parasitic, to prevent or treat COVID-19, even after numerous studies showed it was entirely ineffective against the virus.
Similarly, one recent study estimated that nearly 17,000 deaths occurred across six nations during the first COVID wave after people took hydroxychloroquine, an antimalaria agent that was wrongly promoted to treat and prevent SARS-CoV-2 infection. Although that was a time of crisis, drug repurposing with low-level evidence can be extremely hazardous and even deadly.
Stopping the spread of medical misinformation is an enormous task, and we cannot expect any single entity to accomplish this challenge. Those of us who have taken an oath to protect the health and well-being of patients share the responsibility to separate fact from fiction.
Anything less than a comprehensive effort to prevent the dissemination of medical misinformation -- using the powers of the federal government, public health agencies, healthcare organizations, social media companies and media outlets, and even individual physicians -- abdicates our responsibility and needlessly puts the health of our communities, and our nation, at risk.
Here's my opinion:
These two organizations in their use of the word "American," prove yet again that they have no idea of its meaning.
Over a month earlier, AAPS took the opposite side of the argument.
For those with long memories, AAPS took down Hilary-Care before it had a chance to become law. In effect, we got another generation of relatively free environment of healthcare - or at least a less oppressive system than it would have given us.
Includes links to its amicus brief.
https://aapsonline.org/aaps-files-amicus-brief-against-biden-administrations-censorship/
AAPS Files Amicus Brief Against Biden Administration’s Censorship
The Association of American Physicians and Surgeons (AAPS) has filed an amicus curiae brief in the U.S. Supreme Court in opposition to the censorship imposed by the Biden Administration by pressuring social media to take down postings critical of Covid vaccination. Set for oral argument on Monday, March 18, this is one of the biggest cases before the Supreme Court this term.
Our national motto is not “In Vaccines We Trust,” or even “In Government We Trust,” AAPS states. “The right to criticize vaccines and government mandates of vaccines should not be abridged as brazenly sought” by the Biden Administration and its allies.
The AAPS amicus brief explains that “vaccine hesitancy” is not a psychological condition, as proponents of censorship pretend, “but rather is justified self-defense against a government that abuses its power by imposing vaccine mandates.”
Citing many historical examples of vaccine failures, this brief points out that the “right to criticize a vaccine is essential especially when government flagrantly ignores safety issues,” as the Biden Administration has concerning Covid vaccines.
“The Surgeon General of Florida, our third largest state, cannot obtain answers from the Biden Administration about safety concerns with Covid vaccines,” states Andrew Schlafly as General Counsel of AAPS. “Instead of censoring issues raised about the Covid vaccines on social media, the Biden Administration officials should be providing answers to the questions raised,” he added.
The AAPS brief is particularly critical of an amicus brief filed by the AMA and other groups supportive of Biden’s vaccination policies. “If adopted, the AMA Amici’s arguments would green-light government censorship of the presidential candidate Robert F. Kennedy, Jr., whose motion to intervene in this case to protect his First Amendment rights was denied by this Court,” AAPS’s brief points out.
“When the federal government tells social media platforms to take action against postings, then our basic free speech rights are gravely endangered,” Mr. Schlafly observes.
This case is captioned Murthy v. Missouri (U.S. Sup. Ct. 23-411). Founded in 1943, the Association of American Physicians and Surgeons is a pro-patient association of physicians in the practice of private medicine. Its motto means “all for the patient.”
Link to amicus brief PDF: https://aapsonline.org/judicial/aaps-amicus-murthy-v-missouri-2-7-2024.pdf
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















